Example: Heart Attack

Search clinical trials for: 2,4-thiazolidinedione

Total 114 results

NCT04334005

Not yet recruiting

Vitamin D on Prevention and Treatment of COVID-19

Conditions: Patients Infected With COVID-19
NCT04114136

Not yet recruiting

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

Conditions: Melanoma; Renal Cell Carcinoma; NSCLC; Hepatocellular Carcinoma; Urothelial Cancer; Gastric Adenocarcinoma; HNSCC; Esophageal Adenocarcinoma; Microsatellite Instability-High Solid Malignant Tumor
NCT04017221

Completed

Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

Conditions: Diabetes Mellitus, Type 2; Urosepsis; Diabetic Ketoacidosis; Lower Extremity Amputation
NCT04013581

Not yet recruiting

Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen

Conditions: Type 2 Diabetes Mellitus
NCT03871621

Not yet recruiting

Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial

Conditions: Type 2 Diabetes Mellitus
NCT03646292

Not yet recruiting

Comparison of The Effects of Thiazolidinediones(TZD), Sodium- Glucose Cotransporter 2 Inhibitors(SGLT2i) Alone and TZD / SGLT2i Combination Therapy on Non-alcoholic Fatty Liver Disease in Type 2 Diabetic Patients With Fatty Liver

Conditions: NAFLD - Nonalcoholic Fatty Liver Disease; Type2 Diabetes
NCT03492580

Completed

A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

Conditions: Diabetes Mellitus, Type 2; Cardiovascular Diseases
NCT03486964

Unknown status

Use of Incretins in Diabetic Patients

Conditions: Diabetes Mellitus, Type 2
NCT03471117

Unknown status

Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

Conditions: Chronic Kidney Diseases
NCT03430284

Recruiting

Multifactorial Intervention on Diabetes (MIDiab Study)

Conditions: Diabetes Mellitus, Type 2
NCT03249506

Completed

Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)

Conditions: Diabetes Mellitus, Type 2
NCT02954692

Completed

A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

Conditions: Type 2 Diabetes Mellitus
NCT02887625

Unknown status

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Conditions: Type 2 Diabetes
NCT02857764

Completed

Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States

Conditions: Diabetes Mellitus, Type 2
NCT02730377

Completed

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

Conditions: Diabetes; Diabetes Mellitus, Type 2
NCT02689843

Completed

Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS

Conditions: Polycystic Ovary Syndrome
NCT02653209

Active, not recruiting

TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.

Conditions: Type 2 Diabetes
NCT02476760

Completed

Incretin-based Drugs and Acute Pancreatitis

Conditions: Diabetes Mellitus, Type 2
NCT02475499

Completed

Incretin-based Drugs and Pancreatic Cancer

Conditions: Diabetes Mellitus, Type 2
NCT02456428

Completed

Incretin-based Drugs and the Risk of Heart Failure

Conditions: Type 2 Diabetes Mellitus
NCT02365233

Terminated

Fatty Liver Study in Patients With Type II Diabetes

Conditions: Type II Diabetes; Nonalcoholic Fatty Liver
NCT02320721

Completed

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications

Conditions: Type 2 Diabetes Mellitus
NCT02315287

Recruiting

Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management

Conditions: Type 2 Diabetes
NCT02236962

Unknown status

Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment

Conditions: Type 2 Diabetes; Obesity; Cardiovascular Disease
NCT02231021

Completed

The Practical Evidence of Antidiabetic Combination Therapy in Korea

Conditions: Type 2 Diabetes Mellitus
NCT02219750

Completed

Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients

Conditions: Diabetes
NCT02207374

Completed

A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes

Conditions: Diabetes; Diabetes Mellitus, Type 2
NCT02188186

Completed

Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients

Conditions: Type 2 Diabetes
NCT02140645

Completed

Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy

Conditions: Diabetes Mellitus, Type 2
NCT02043054

Completed

Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

Conditions: Type 2 Diabetes Mellitus; Cardiovascular Disease
NCT02015780

Withdrawn

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Conditions: Type 2 Diabetes Mellitus; Chronic Kidney Disease
NCT01972542

Completed

The Usefulness of Postprandial Triglyceride for Assessment of Cardiovascular Risk

Conditions: Diabetes; Prediabetes
NCT01945242

Completed

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

Conditions: Type 2 Diabetes Melitus
NCT01777282

Completed

A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus
NCT01697592

Completed

Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

Conditions: Type 2 Diabetes Mellitus
NCT01631630

Terminated

Role of Proinflammatory Signaling in Alcohol Craving

Conditions: Alcohol Dependence; Alcohol Drinking; Stress; Alcohol-Related Disorders
NCT01503008

Withdrawn

Proteus Sustained Behavior Change Study

Conditions: Type 2 Diabetes Mellitus
NCT01468181

Completed

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT01421459

Completed

A Study in Adults With Type 2 Diabetes

Conditions: Diabetes Mellitus, Type 2
NCT01368081

Completed

Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT01223196

Completed

Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT01175486

Unknown status

Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy

Conditions: Diabetes
NCT01147627

Completed

Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

Conditions: Diabetes Mellitus, Type 2; Newly Diagnosed
NCT01135394

Completed

Pharmacogenomics of Thiazolidinediones

Conditions: Type 2 Diabetes
NCT01124656

Terminated

Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes

Conditions: Diabetes Mellitus, Type 2
NCT01106651

Completed

A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT01077323

Completed

A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents

Conditions: Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies); Healthy Subjects (Treated With no Diabetes Therapies)
NCT01068860

Completed

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Conditions: Type 2 Diabetes Mellitus; Impaired Glucose Tolerance
NCT01055223

Completed

Fracture Risk With Thiazolidinediones

Conditions: Fractures, Bone; Type II Diabetes
NCT01040819

Completed

Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?

Conditions: Type 2 Diabetes Mellitus